LT2049148T - Žmogaus augimo hormono skysta stabili kompozicija - Google Patents
Žmogaus augimo hormono skysta stabili kompozicijaInfo
- Publication number
- LT2049148T LT2049148T LTEP06769186.5T LT06769186T LT2049148T LT 2049148 T LT2049148 T LT 2049148T LT 06769186 T LT06769186 T LT 06769186T LT 2049148 T LT2049148 T LT 2049148T
- Authority
- LT
- Lithuania
- Prior art keywords
- growth hormone
- liquid formulation
- human growth
- stable liquid
- stable
- Prior art date
Links
- 102000002265 Human Growth Hormone Human genes 0.000 title 1
- 108010000521 Human Growth Hormone Proteins 0.000 title 1
- 239000000854 Human Growth Hormone Substances 0.000 title 1
- 239000012669 liquid formulation Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/27—Growth hormone [GH], i.e. somatotropin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/KR2006/002640 WO2008004717A1 (en) | 2006-07-06 | 2006-07-06 | A stable liquid formulation of human growth hormone |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT2049148T true LT2049148T (lt) | 2016-11-25 |
Family
ID=38894670
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP06769186.5T LT2049148T (lt) | 2006-07-06 | 2006-07-06 | Žmogaus augimo hormono skysta stabili kompozicija |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US8409586B2 (lt) |
| EP (1) | EP2049148B1 (lt) |
| JP (1) | JP5180202B2 (lt) |
| CN (1) | CN101505789A (lt) |
| BR (1) | BRPI0621841B8 (lt) |
| ES (1) | ES2605022T3 (lt) |
| HK (1) | HK1216992A1 (lt) |
| HU (1) | HUE031329T2 (lt) |
| LT (1) | LT2049148T (lt) |
| PT (1) | PT2049148T (lt) |
| WO (1) | WO2008004717A1 (lt) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2011001273A (ja) * | 2009-06-16 | 2011-01-06 | Eci Inc | ｅＭＩＰを有効成分とする水溶性製剤 |
| IN2012DN02861A (lt) * | 2009-11-17 | 2015-07-24 | Ipsen Pharma Sas | |
| WO2013096835A1 (en) * | 2011-12-23 | 2013-06-27 | Abbvie Inc. | Stable protein formulations |
| IN2013MU03559A (lt) * | 2013-11-12 | 2015-07-24 | Cadila Healthcare Ltd | |
| US9908976B2 (en) | 2015-03-18 | 2018-03-06 | Psmg, Llc | Stable polyethylene glycol particle dispersions and methods for forming the stable dispersions |
| CN110151988A (zh) * | 2018-02-11 | 2019-08-23 | 百奥泰生物制药股份有限公司 | 一种靶向治疗TNF-α相关疾病的人抗体制剂 |
Family Cites Families (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS61296598A (ja) | 1985-06-21 | 1986-12-27 | Mitsubishi Electric Corp | Ｍｏｓダイナミツクｒａｍのダミ−ワ−ド線駆動回路 |
| DE3782737T3 (de) * | 1987-08-21 | 1999-05-20 | Imcera Group Inc., Northbrook, Ill. | Stabilisierung von Wachstumshormonen. |
| US5981485A (en) | 1997-07-14 | 1999-11-09 | Genentech, Inc. | Human growth hormone aqueous formulation |
| CA2489978A1 (en) * | 1992-07-31 | 1994-02-17 | Genentech, Inc. | Human growth hormone aqueous formulation |
| ZA965368B (en) * | 1995-07-14 | 1997-01-14 | Novo Nordisk As | A pharmaceutical formulation |
| KR970006498A (ko) | 1995-07-31 | 1997-02-21 | 유충식 | 활성형 인성장호르몬의 정제 방법 |
| AUPN801296A0 (en) * | 1996-02-12 | 1996-03-07 | Csl Limited | Stabilised growth hormone formulation and method of preparation thereof |
| US20020077461A1 (en) * | 1996-04-24 | 2002-06-20 | Soren Bjorn | Pharmaceutical formulation |
| KR100210840B1 (ko) | 1996-12-24 | 1999-07-15 | 구본준 | 기계 화학적 연마 방법 및 그 장치 |
| KR19990001217A (ko) | 1997-06-13 | 1999-01-15 | 윤종용 | 스탠바이 모드에서의 시스템 구동방법 및 장치 |
| JP3723857B2 (ja) | 1998-02-04 | 2005-12-07 | 日本ケミカルリサーチ株式会社 | ヒト成長ホルモン含有水性医薬組成物 |
| KR100316347B1 (ko) | 1998-09-15 | 2002-08-27 | 한미약품(주) | 대장균엔테로톡신ⅱ신호펩티드의변형체와인체성장호르몬의융합단백질을발현하는재조합미생물및그를이용한인체성장호르몬의제조방법 |
| KR100573704B1 (ko) | 1998-12-02 | 2006-07-21 | 동아제약주식회사 | 인성장 호르몬의 안정화된 액상제제_ |
| BRPI0017437B8 (pt) * | 1999-10-04 | 2021-05-25 | Chiron Corp | composição farmacêutica estabilizada contendo polipeptídeo il-2, método para aumentar estabilidade de interleucina-2 em uma composição farmacêutica, e uma forma seca da composição |
| BR9917517A (pt) | 1999-10-08 | 2002-07-30 | Shearwater Corp | Derivados poliméricos heterobifuncionais e processo para a preparação dos mesmos |
| KR20030023878A (ko) * | 2000-06-26 | 2003-03-20 | 몬산토 테크놀로지 엘엘씨 | 소마토트로핀의 지속적인 방출을 위한 계면활성제 함유비수성 제제들 |
| CN1668332A (zh) * | 2002-07-09 | 2005-09-14 | 桑多斯股份公司 | 包含苯酚的含高浓度人生长激素的液体制剂 |
| EP1603588A2 (en) * | 2003-03-18 | 2005-12-14 | Ares Trading S.A. | Stabilisation of growth hormones in solution |
| KR100537260B1 (ko) | 2003-09-03 | 2005-12-19 | 한미약품 주식회사 | 인간 성장 호르몬의 안정화된 액상 제제용 조성물 |
| EP1667724A2 (en) | 2003-09-19 | 2006-06-14 | Novo Nordisk A/S | Albumin-binding derivatives of therapeutic peptides |
| EP1663296A4 (en) * | 2003-09-25 | 2009-11-25 | Cangene Corp | LIQUID FORMULATION OF HUMAN GROWTH HORMONE CONTAINING POLYETHYLENE GLYCOL |
| DE10355189B4 (de) * | 2003-11-26 | 2015-04-30 | Johnson & Johnson Medical Gmbh | Verfahren zum Herstellen eines chirurgischen Implantats sowie chirurgisches Implantat |
| ES2383691T3 (es) * | 2003-12-23 | 2012-06-25 | Pharmacia Corporation | Formulación líquida estable de hormonas de crecimiento |
-
2006
- 2006-07-06 EP EP06769186.5A patent/EP2049148B1/en active Active
- 2006-07-06 US US12/307,661 patent/US8409586B2/en active Active
- 2006-07-06 ES ES06769186.5T patent/ES2605022T3/es active Active
- 2006-07-06 BR BRPI0621841A patent/BRPI0621841B8/pt active IP Right Grant
- 2006-07-06 JP JP2009517937A patent/JP5180202B2/ja active Active
- 2006-07-06 WO PCT/KR2006/002640 patent/WO2008004717A1/en active Application Filing
- 2006-07-06 PT PT67691865T patent/PT2049148T/pt unknown
- 2006-07-06 LT LTEP06769186.5T patent/LT2049148T/lt unknown
- 2006-07-06 HU HUE06769186A patent/HUE031329T2/hu unknown
- 2006-07-06 CN CNA2006800556995A patent/CN101505789A/zh active Pending
-
2016
- 2016-04-29 HK HK16104967.3A patent/HK1216992A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2008004717A1 (en) | 2008-01-10 |
| CN101505789A (zh) | 2009-08-12 |
| EP2049148A4 (en) | 2013-12-11 |
| PT2049148T (pt) | 2016-12-30 |
| US20090298768A1 (en) | 2009-12-03 |
| WO2008004717A9 (en) | 2013-08-29 |
| JP2009542629A (ja) | 2009-12-03 |
| HK1216992A1 (zh) | 2016-12-16 |
| JP5180202B2 (ja) | 2013-04-10 |
| BRPI0621841B1 (pt) | 2020-12-29 |
| EP2049148A1 (en) | 2009-04-22 |
| US8409586B2 (en) | 2013-04-02 |
| ES2605022T3 (es) | 2017-03-10 |
| EP2049148B1 (en) | 2016-09-28 |
| HUE031329T2 (hu) | 2017-07-28 |
| BRPI0621841B8 (pt) | 2021-05-25 |
| BRPI0621841A2 (pt) | 2011-12-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1216992A1 (zh) | 穩定的人生長激素液體製劑 | |
| EP2593084A4 (en) | LIQUID FORMULATION FROM HUMAN GROWTH HORMONE CONJUGATES WITH LONG-TERM EFFECT | |
| ZA200904544B (en) | Stable S-(+)-abscisic acid liquid and soluble granule formulations | |
| EP2081502B8 (en) | A medical device for attaching tissue to bone | |
| PL2007356T3 (pl) | Preparaty lipopleksowe przeznaczone do swoistego dostarczania do tkanek naczyniowych śródbłonka | |
| HK1181633A1 (en) | Endoscopic delivery of medical devices | |
| EP1942981A4 (en) | DISTRIBUTION OF MEDIUM TO TISSUE | |
| ZA200900345B (en) | Preparation of pharmaceutical formulations | |
| PT1986606T (pt) | Formulações líquidas contendo fenilefrina | |
| EP2512460A4 (en) | METHOD AND COMPOSITIONS FOR STABLE LIQUID ACTIVE FORMULATIONS | |
| EP2081607A4 (en) | HYGIENE TOWEL WITH A MICROBIAL SUPPRESSIVE COMPOSITION | |
| PL1570866T3 (pl) | Sposób dostarczania płynnego środka sterylizującego do sterylizatora | |
| HK1200019A1 (en) | Use of a liquid allergy vaccine formulation for oromucosal administration | |
| HK1142536A1 (en) | Gel useful for the delivery of cosmetic active ingredients | |
| ZA200900125B (en) | Liquid formulation of pyrethroids | |
| ZA200704926B (en) | Modified human growth hormone | |
| HK1131546A1 (en) | Subcutaneous implants releasing an active principle over an extended period of time | |
| IL213711A (en) | Nano-phenofibrate preparation | |
| ZA200809269B (en) | Liquid pharmaceutical formulation | |
| EP2073631A4 (en) | AGROCHEMICAL FORMULATIONS OF LIQUID CRYSTALS | |
| HK1215930A1 (zh) | 穩定的人生長激素液體製劑 | |
| HK1144295A1 (en) | Stable liquid formulation | |
| IL199756A0 (en) | Medically active plaster | |
| GB0813004D0 (en) | Stable therapeutic formulation of human growth hormone | |
| GB2451360B (en) | Hormone replacement formulation |